Takeda GmbH

25 products tracked · names used in filings: Takeda GmbH, Takeda Pharma A/S, Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals International AG Ireland

Upcoming milestones

No upcoming milestones listed.

Recent milestones

No recent milestones.

Products

ProductStatusApproved
🇪🇺Exkivity
mobocertinib		Application withdrawn
🇪🇺Fruzaqla
fruquintinib		Authorised2024-06-20
🇪🇺Alunbrig
brigatinib		Authorised2018-11-22
🇪🇺Alofisel
darvadstrocel		Withdrawn2018-03-23
🇪🇺Ninlaro
ixazomib		Authorised2016-11-21
🇪🇺Intuniv
guanfacine		Authorised2015-09-17
🇪🇺Entyvio
vedolizumab		Authorised2014-05-22
🇪🇺Incresync
alogliptin;pioglitazone		Authorised2013-09-19
🇪🇺Vipidia
alogliptin benzoate		Authorised2013-09-18
🇪🇺Vipdomet
alogliptin;metformin		Authorised2013-09-18
🇪🇺Adcetris
brentuximab vedotin		Authorised2012-10-25
🇪🇺Revestive
teduglutide		Authorised2012-08-30
🇪🇺Rienso
ferumoxytol		Withdrawn2012-06-15
🇪🇺Edarbi
azilsartan medoxomil		Authorised2011-12-07
🇪🇺Ipreziv
azilsartan medoxomil		Withdrawn2011-12-07
🇪🇺Resolor
prucalopride		Authorised2009-10-14
🇪🇺Somac Control
pantoprazole		Authorised2009-06-12
🇪🇺Pantecta Control
pantoprazole		Withdrawn2009-06-12
🇪🇺Controloc Control
pantoprazole		Authorised2009-06-11
🇪🇺Pantoloc Control
pantoprazole		Withdrawn2009-06-11
🇪🇺Pantozol Control
pantoprazole		Authorised2009-06-11
🇪🇺Firazyr
icatibant		Authorised2008-07-11
🇪🇺Glubrava
pioglitazone;metformin		Withdrawn2007-12-11
🇪🇺Xagrid
anagrelide		Authorised2004-11-15
🇪🇺Glustin
pioglitazone		Withdrawn2000-10-11

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.